MAPT and Alzheimer disease: Studies in AD rodent models have implicated the classical pathway in pathological synaptic loss; C1q is deposited on synapses destined for elimination, and synaptic elimination is reduced or abolished by either C1q deletion or blocking of C1q with inhibitory antibodies in both amyloid and tau models [28, 29].